Table 2.
Management of patients.
| Variable | All patients N = 106 |
ICU admission N = 16 |
No ICU admission N = 90 |
p value |
|---|---|---|---|---|
| Mechanical ventilation, N (%) | 9 (8.7) | 9 (69.2) | 0 (0) | <0.001 |
| Vasopressors, N (%) | 6 (5.7) | 6 (37.5) | 0 (0) | <0.001 |
| Use of steroids, N (%) | 58 (54.7) | 10 (62.5) | 48 (53.3) | 0.50 |
| Initial daily dose (mg of prednisone or equivalent), median (Q1, Q3) | 120 (40, 120) | 50 (40, 105) | 120 (50, 120) | 0.02 |
| Antimicrobial therapy, N (%) | ||||
| No initial antibiotic | 7 (6.7) | 0 (0) | 7 (8) | 0.60 |
| Fluoroquinolones | 4 (3.8) | 0 (0) | 4 (4.5) | 1.0 |
| Beta lactam alone | 13 (12.3) | 1 (6.3) | 12 (13.3) | 0.69 |
| Antipseudomonal beta lactam | 7 (6.6) | 2 (12.5) | 5 (5.6) | 0.28 |
| Beta lactam + azithromycin | 43 (40.6) | 3 (18.8) | 40 (44.4) | 0.06 |
| Antipseudomonal beta lactam + azithromycin | 30 (28.3) | 10 (62.5) | 20 (22.2) | 0.002 |
| Oseltamivir, N (%) | 73/106 (68.9) | 10 (62.5) | 63/90 (70) | 0.55 |
ICU: intensive care unit, Q1: first quartile, and Q3: third quartile.